NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









ProteinQure

ProteinQure

Private
TorontoHealthcare & Life Scienceshttps://www.proteinqure.com/

Last Round

Grant

May 27, 2026

Total Funding Raised

$19.02M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

ProteinQure is a biotechnology company that has developed a computational platform for the design of peptide-based therapeutics using quantum computing, artificial intelligence, and molecular dynamics simulations.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Quantum Computing, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

peptide drug discoveryAI drug discoverypeptide therapeuticsAI biotechAI-first biotechcomputational drug designpeptide-drug conjugatesin silico drug designmolecular simulationbiotech R&Dquantum computingdrug discovery platformpharma partnershipsoncology therapeuticsdrug discovery pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ProteinQure Comps

Public and private peers based on sector, stage, and business model.

ProteinQure comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

ProteinQure Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 27, 2026
GrantApr 7, 2026
Series AMay 28, 2025
GrantJan 21, 2025
GrantFeb 22, 2024
Seed
Jul 25, 2019

Key People

Founding team and executive leadership

Christopher Ing

Co-Founder And Chief Scientific Officer

Founding Team

Mark Fingerhuth

Co-Founder And Chief R D Officer

Founding Team

Tomas Babej

Cofounder and Chief Technology Officer

Founding Team

Lucas Siow

Co-Founder - CEO

Founding Team

ProteinQure Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 7, 2026

    $1.86M grant received

  • May 28, 2025

    $11M round completed.

ProteinQure Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ProteinQure Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ProteinQure's valuation, stock price, and market status.

Firmographic Details

HeadquartersToronto
Employee Range32
Year Founded2017
Last FundingMay 27, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.